322 results on '"Scher, Jose U."'
Search Results
2. Metabolic coordination between skin epithelium and type 17 immunity sustains chronic skin inflammation
3. Prevention of Psoriatic Arthritis: The Need for Prospective Studies
4. Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry
5. Responsiveness and Minimum Clinically Important Difference in Patient‐Reported Outcome Measures Among Patients With Psoriatic Arthritis: A Prospective Cohort Study
6. Psoriatic arthritis from a mechanistic perspective
7. New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine
8. Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
9. National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments
10. CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health
11. Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation
12. Microbial-derived antigens and metabolites in spondyloarthritis
13. Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study
14. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
15. Key opinion leaders — a critical perspective
16. Auto-deconvolution and molecular networking of gas chromatography–mass spectrometry data
17. Mitigation of Osteoclast‐Mediated Arthritic Bone Remodeling By Short Chain Fatty Acids.
18. Not your average joint: Towards precision medicine in psoriatic arthritis
19. Psoriatic arthritis
20. KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease
21. Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response
22. Use of the Bath Ankylosing Spondylitis Disease Activity Index in Patients With Psoriatic Arthritis With and Without Axial Disease.
23. Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis Via COX-1
24. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition
25. Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMAN
26. Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study
27. Strategies to Improve Outcomes in Psoriatic Arthritis
28. Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings.
29. Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center.
30. Human microbiome, infections, and rheumatic disease
31. Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up
32. Inflammasome Signaling and Impaired Vascular Health in Psoriasis
33. Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
34. 22 - The microbiome in rheumatic diseases
35. Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious Spondyloarthritis
36. The role of the gut microbiome in systemic inflammatory disease
37. The 2018 landscape of RA, PsA, and SpA pathogenesis
38. Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin.
39. Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry
40. COVID-19 outcomes in patients with psoriasis and psoriatic arthritis: A prospective cohort study
41. Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City
42. Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
43. A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation
44. 07.04 Partial elimination of intestinal microbiota dampens t helper 17 cell differentiation and established collagen-induced arthritis in mice
45. Short- and long-term effects of oral vancomycin on the human intestinal microbiota
46. Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis.
47. Spondyloarthritis and the Microbiome: New Insights From an Ancient Hypothesis
48. Biomarkers in Psoriatic Arthritis: Recent Progress
49. Diet-Induced Arthritis in Pigs: Comment on the Article by Scher et al
50. Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.